Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$7.37M in Q4 2019 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2020. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2020 · filed November 05, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Minerva Neurosciences Inc | Exited | +0 | — | — |
quarter ended June 30, 2020 · filed August 12, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Minerva Neurosciences Inc | Trimmed | −1,036,250 | — | — |
quarter ended March 31, 2020 · filed May 11, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Elastic N V | Exited | +0 | — | — |
Loading...
